Compare Chaperone Technologies vs PDS Biotechnology
Customers evaluate the quality of Chaperone Technologies's products using the following success metrics.
Overview
Chaperone Technologies is based in United States
Chaperone Technologies, Inc. is developing antimicrobial products, based on a novel and proprietary mechanism of action, for difficult-to-treat and drug-resistant organisms across a broad range of infectious diseases. Chaperone's proven technology has already yielded the company's first product, a potent antimicrobial which is in development for treating complicated drug resistant Urinary Tract Infections.
PDS Biotechnology is based in United States
PDS Biotechnology is a company with a growing pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, cervical cancer, anal cancer, prostate cancer, and breast cancer, and other cancers.
Demo Video
Leadership
Kenneth E Kovan (President)
Frank Bedu-Addo (Chief Executive Officer)
Funding
Investors
Life Sciences Greenhouse of Central Pennsylvania
Edge Therapeutics, NetScientific
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Chaperone Technologies has not claimed their profile.
Work for Chaperone Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Chaperone Technologies?
Claim your profile now.
Information not available because PDS Biotechnology has not claimed their profile.
Work for PDS Biotechnology? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for PDS Biotechnology?
Claim your profile now.